Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report
Cureus · 24.05.2023
DOI: 10.7759/cureus.39439 ↗Kurz gefasst
Fallbericht in der Zeitschrift Cureus, erschienen am 24.05.2023. Verfasst von Guy Hayakawa und 3 weiteren Autor:innen. Beteiligte Einrichtung: General Medicine, Peterborough City Hospital, Peterborough, GBR. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- General Medicine, Peterborough City Hospital, Peterborough, GBR.
- Oncology, Peterborough City Hospital, Peterborough, GBR.
- Diabetes and Endocrinology, Peterborough City Hospital, Peterborough, GBR.
Zitieren
APA
Hayakawa, G., Leibowitz, M. M., Datta, S., & Oyibo, S. O. (2023). Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report. Cureus. https://doi.org/10.7759/cureus.39439
Vancouver
Hayakawa G, Leibowitz MM, Datta S, Oyibo SO. Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report. Cureus. 2023. doi:10.7759/cureus.39439
BibTeX
@article{Hayakawa2023,
author = {Hayakawa, Guy and Leibowitz, Maya M and Datta, Sudipta and Oyibo, Samson O},
title = {Transient Thyroiditis Followed by Exacerbation of Hypothyroidism After Immune Checkpoint Inhibitor Therapy (Nivolumab and Ipilimumab) in a Patient With Pre-existing Autoimmune Hypothyroidism: A Case Report},
journal = {Cureus},
year = {2023},
doi = {10.7759/cureus.39439}
}
EUVIMED